Deteriorating stroke: Diagnostic criteria, predictors, mechanisms and treatment

Cerebrovascular Diseases

Volumn 9, Issue 3 SUPPL., 1999, Pages 1-8

  Castillo, José ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROVASCULAR DISEASE; DISEASE COURSE; HUMAN; REVIEW;

CEREBROVASCULAR DISORDERS; DISEASE PROGRESSION; HUMANS;

EID: 0032610024     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047548     Document Type: Article

References (83)

1. Britton M, Rödén A: Progression of stroke after arrival at hospital. Stroke 1985;16:629-632.
2. Dávalos A, Cendra E, Teruel J, Martínez M, Genís D: Deteriorating ischemic stroke: Risk factors and prognosis. Neurology 1990;40: 1865-1869.
3. Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS: Effect of blood pressure and diabetes on stroke in progression. Lancet 1994;344: 156-159.
4. Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C, Pozzilli C, Fieschi C: Progressing neurological deficit secondary to acute ischemic stroke. Arch Neurol 1995;52: 670-675.
5. Castillo J, Dávalos A, Noya M: Progression of ischaemic stroke and excitotoxic amino acids. Lancet 1997;349:79-83.
6. Dávalos A, Castillo J, Pumar JM, Noya M: Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis 1997;7:64-69.
7. Yamomoto H, Bogousslavsky J, van Melle G: Predictors of neurological worsening in acute ischemic stroke. Stroke 1997;28:251.
8. Dávalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J, for the ECASS Group: Neurological deterioration in acute ischemic stroke. Potential predictors and associated factors in the European Cooperative Acute Stroke Study. Stroke, submitted.
9. Asplund K: Deterioration of acute stroke; in del Zoppo GJ, Mori E, Hacke W (eds): Thrombolytic Therapy in Acute Ischemic Stroke II. Berlin, Springer, 1993, pp 119-128.
10. Mayer SA, Sacco RL, Shi T, Mohr JP: Neurological deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology 1994;44:1379-1384.
11. Rödén-Jüllig A: Progressing stroke: Epidemiology. Cerebrovasc Dis 1997;7(suppl 5):2-5.
12. Dávalos A, Castillo J: Progressing stroke; in Fisher M, Bogousslavsky J (eds): Current Review of Cerebrovascular Disease, ed 3. Philadelphia, Current Medicine, 1999, pp 149-160.
13. Dávalos A, Castillo J: Potential mechanisms of worsening. Cerebrovasc Dis 1997;7(suppl 5): 19-24.
14. Castillo J, Dávalos A, Leira R, Noya M: Generalized headache at the onset of ischemic stroke predicts neurological worsening (abstract). Stroke 1998;29:316.
15. Castillo J, Dávalos A, Noya M: Timing for fever-related brain damage in acute ischemic stroke. Stroke 1998;29:2455-2460.
16. Castillo J, Noya M: The prevention and treatment of medical complications in hospitalized stroke patients; in Castillo J, Dávalos A, Toni D (eds): Management of Acute Ischemic Stroke. Barcelona, Springer, 1997, pp 67-80.
17. Schellinger P, Schwab S, Hacke W: Early management of cerebral vascular disease; in Castillo J, Dávalos A, Toni D (eds): Management of Acute Ischemic Stroke. Barcelona, Springer, 1997, pp 48-66.
18. Castillo J, Martínez F, Leira R, Prieto JM, Lema M, Noya M: Mortality and morbidity of acute cerebral infarction related to temperature and basal analytic parameters. Cerebrovasc Dis 1994;4:66-71.
19. Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli L, Re G, D'Allessandro R: Fever in acute stroke worsens prognosis. Stroke 1996; 26:2040-2043.
20. Reith J, Jørgensen HO, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS: Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996;347:422-425.
21. Castillo J, Martínez F, Corredera E, Aldrey JM, Noya M: Amino acid transmitters in patients with headache during the acute phase of cerebrovascular ischemic disease. Stroke 1995;26: 2035-2039.
22. Castillo J, Dávalos A, Lema M, Serena J, Noya M: Glutamate is a marker for cerebral ischemia in cortical but not deep infarcts. Cerebrovasc Dis 1997;7:245-250.
23. Toni D, Fiorelli M, Bastianello S, Sachetti ML, Sette G, Argentino C, Montinazo E, Bozzao L: Hemorrhagic transformation of brain infarct: Predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 1996;46:341-345.
24. Chamorro A, Vila N, Saiz A, Alday M, Tolosa E: Early anticoagulation after large cerebral embolic infarct: A safety study. Neurology 1995;45:861-865.
25. Toni D: Diagnostic evaluation in the acute phase and the early clinical course; in Castillo J, Dávalos A, Toni D (eds): Management of Acute Ischemic Stroke. Barcelona, Springer, 1997, pp 16-34.
26. Von Kummer R, Meyding-Lamadé V, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K: Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. Am J Neuroradiol 1994;15:9-15.
27. Fisher M, García JH: Evolving stroke and the ischemic penumbra. Neurology 1996;47:884-888.
28. Marchal G, Serrati C, Rioux P, Petit-Taboué MC, Viader F, de la Savette V, Le Doze F, Lochon P, Derlon JM, Orgogozo J, Baron JC: PET imaging of cerebral perfusion and oxygen consumption in acute ischemic stroke: Relation to outcome. Lancet 1993;341:925-927.
29. Lutsep HL, Albers GW, De Crespigny A, Kamat GN, Marks MP, Moseley ME: Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 1997;41:574-580.
30. Baird AE, Benfield A, Schlaug G, Siewet B, Lövblad KO, Edelman RR, Warach S: Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;41: 581-589.
31. Toni D, Fiorelli M, Zanette EM, Sachetti ML, Salerno A, Argentino C, Solaro M, Fieschi C: Early spontaneous improvement and deterioration of ischemic stroke patients. A serial study with transcranial Doppler ultrasonography. Stroke 1998;29:1144-1148.
32. Naveiro J, Castillo J, Suárez P, Aldrey JM, Lema M, Noya M: Tiempo para el daño cerebral por hiperglucemia en la isquemia aguda. Rev Neurol 1998;26:790-793.
33. Toni D: Predictors of stroke deterioration. Cerebrovasc Dis 1997;7(suppl 5):10-13.
34. Fisher M: Characterising the target of acute stroke therapy. Stroke 1997;28:866-872.
35. Hossmann KA: Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36:557-565.
36. Castillo J, Dávalos A, Naveiro J, Noya M: Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996;27:1060-1065.
37. Samdani AF, Dawson TM, Dawson VL: Nitric oxide synthase in models of focal ischemia. Stroke 1997;28:1283-1288.
38. Iadecola C, Zhang F, Xu S, Casey R, Ross ME: Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 1995;15:378-384.
39. Castillo J, Dávalos A, Naveiro J, Armengou A, Noya M: A reduction in L-arginine levels during acute stroke is associated with greater cerebral damage. Cerebrovasc Dis 1997;7(suppl 4): 82.
40. Dávalos A, Fernández-Real JM, Ricart W, Soler S, Molins A, Planas E, Genis D: Iron-related damage in acute ischemic stroke. Stroke 1994; 25:1543-1546.
41. Armengou A, Fernández-Real JM, Castillo J, Dávalos A: Serum ferritin concentrations are not modified in the acute phase of ischemic stroke. Stroke 1998;29:258-260.
42. Qiu H, Hedlund LW, Gewalt SL, Benveniste H, Bare TM, Johnson GA: Progression of a focal ischemic lesion in rat brain during treatment with a novel glycine/NMDA antagonist: An in-vivo three-dimensional diffusion-weighted MR microscopy study. J Magn Reson Imaging 1997;7:739-744.
43. Di X, Bullock R, Watson J, Fatouros P, Chenard B, White F, Corwin F: Effect of CP101, 606, a novel NR2B sub-unit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage and cytotoxic brain edema after middle cerebral artery occlusion in the feline brain. Stroke 1997;28:2244-2251.
44. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R: A malignant middle cerebral territory infarction. Arch Neurol 1996;53:314-315.
45. Toni D, De Michele M, Fiorelli M, Bastianello S, Camerlingo M, Sachetti ML, Argentino C, Fieschi C: Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion. J Neurol Sci 1994;123:129-133.
46. Kanthan R, Shuaib A, Griebel R, Miyashita H, Kalra J: Glucose-induced decrease in glutamate levels in ischemic human brain by in-vivo microdialysis. Neurosci Lett 1996;209:207-209.
47. Takagi T, Ginsberg MD, Globus MYT, Martínez E, Busto R: Effect of hyperthermia in glutamate release in ischemic penumbra after middle cerebral artery occlusion in rats. Am J Physiol 1994;266:1770-1776.
48. Castillo J, Dávalos AM, Noya M: Aggravation of acute ischemic stroke by hyperthermia is related to an excitotoxic mechanism. Cerebrovasc Dis 1999;9:22-27.
49. Madl JE, Allen DL: Hyperthermia depletes adenosine triphosphate and decreases glutamate uptake in rat hippocampal slices. Neuroscience 1995;62:395-405.
50. Globus MYT, Busto R, Lin B, Schnippering H, Ginsberg MD: Detection of free radical activity during transient global ischemia and recirculation: Effects of intraischemic brain temperature modulation. J Neurochem 1995;65:1250-1216.
51. Reith J, Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS: Seizures in acute stroke: Predictors and prognostic significance. The Copenhagen Stroke Study. Stroke 1997;28: 1585-1589.
52. Dávalos A, Cendra E, Molins A, Ferrandiz M, López-Pousa S, Genís D: Epileptic seizures at the onset of stroke. Cerebrovasc Dis 1992;2: 327-331.
53. Castillo J, Corredera E, Martínez F, Prieto JM, Leira R, Noya M: Crises comiciales en la fase aguda de la enfermedad vascular cerebral. Rev Esp Neurol 1994;9:115-119.
54. Arboix A, Comes E, Massons J, Garcia L, Oliveres M: Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease. Neurology 1996;47:1429-1435.
55. Bladin CF, Norris JW: Stroke and seizures/epilepsy; in Welch KMA, Caplan LR, Reis D, Siesj BK, Weir B (eds): Primer on Cerebrovascular Diseases. San Diego, Academic Press, 1997, pp 355-358.
56. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takashaski K, Iwama H, Nishihawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hoi S, Takinoto M, Wada K: Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997;276:1699-1702.
57. Toni D, Fiorelli M, Bastianello S, Falcon A, Sette G, Ceschin V, Sachetti ML, Argentino C: Acute ischemic stroke improving during the first 48 hours of onset: Predictability, outcome, and possible mechanisms. A comparison with early deteriorating strokes. Stroke 1997;22:10-14.
58. Dawson DA, Ruetzler CA, Hallenbeck JM: Temporal impairment of microcirculatory perfusion following focal cerebral ischemia in the spontaneously hypertensive rat. Brain Res 1997;749:200-208.
59. Kawai N, Keep RF, Betz Al: Hyperglycemia and the vascular effects of cerebral ischemia. Stroke 1997;28:149-154.
60. Witte OW, Stoll G: Delayed and remote effects of focal cortical infarctions: Secondary damage and reactive plasticity. Adv Neurol 1997;73: 207-227.
61. Gidday JM, Park TS, Gonzales ER, Beetsch JW: CD 18-dependent leukocyte adherence and vascular injury in pig cerebral circulation after ischemia. Am J Physiol 1997;272:2622-2629.
62. Kim JS, Yoon SS, Kim YH, Ryu JS: Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 1996;27:1553-1557.
63. Elneihoum AM, Falke P, Axelsson L, Lundberg E: Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 1996;27:1734-1738.
64. Back T, Zhao W, Ginsberg MD: Three-dimensional image-analysis of brain glucose metabolism/blood flow uncoupling and its electrophysiological correlates in the acute ischemic penumbra following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1995;15:566-577.
65. Obrenovitch TP: The ischemic penumbra: Twenty years on. Cerebrovasc Brain Metab Rev 1995;7:297-323.
66. Kitanaka C, Teraoka A: Clinical features of progressive lacunar infarction: Retrospective analysis of patients with motor syndromes. Neurol Med Chir 1995;35:663-666.
67. Jørgensen HS, Nakayama H, Olsen TS: Treatment of arterial hypertension in acute stroke; in Castillo J, Dávalos A, Toni D (eds): Management of Acute Ischemic Stroke. Barcelona, Springer, 1997, pp 81-87.
68. Rordorf G, Cramer SC, Efird JT, Schwamm LH, Buonanno F, Koroshetz WJ: Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 1997; 28:2133-2138.
69. García JH, Liu KF, Ho KL: Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke 1995;26: 636-642.
70. Du C, Hu R, Csernansky CA, Hsu CY, Choi DW: Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis? J Cereb Blood Flow Metab 1996;16:195-201.
71. Bonfoco E, Krainc D, Ancarcrona M, Nicotera P, Lipton SA: Apoptosis and necrosis: Two distinct events induced respectively by mild and intense insult with NMDA or nitric oxide/ superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995;91:7162-7166.
72. Zivin JA: Factors determining the therapeutic window for stroke. Neurology 1998;50:599-603.
73. Ginsberg MD, Pulsinelli WA: The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann Neurol 1994;36:553-554.
74. Kim JS: Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 1996; 137:69-78.
75. The European Ad Hoc Consensus Group: European strategies for early intervention in stroke. Cerebrovasc Dis 1996;6:315-324.
76. Dávalos A, Castillo J, Martínez-Vila E, for the Cerebrovascular Study Group of the Spanish Neurological Society: Delay in neurological attention and stroke outcome. Stroke 1995;26: 2233-2237.
77. Dávalos A, Toni D, Castillo J: Remarks on the management of acute ischemic stroke; in Castillo J, Dávalos A, Toni D (eds): Management of Acute Ischemic Stroke. Barcelona, Springer, 1997, pp 265-271.
78. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Saverbeck L, Spilker J, Duldnar J, Khoury J: Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28:1-5.
79. The European Ad Hoc Consensus Group: Neuroprotection as initial therapy in acute stroke. Cerebrovasc Dis 1998;8:59-72.
80. Rordorf G, Cramer SC, Efird JT, Schwamm LH, Buonanno F, Koroshetz WJ: Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 1997; 28:2133-2138.
81. Hacke W, Steiner T, Schwab S: Critical management of acute stroke: Medical and surgical therapy; in Batjer HH, Caplan LR, Friberg L, Greenlee RG, Kopitnik TA, Young WL (eds): Cerebrovascular Disease. Philadelphia, Lippincott-Raven, 1997, pp 523-533.
82. Gil-Peralta A: Surgical interventions in the acute phase of ischemic stroke; in Castillo J, Dávalos A, Toni D (eds): Management of Acute Ischemic Stroke. Barcelona, Springer, 1997, pp 240-252.
83. Dávalos A, Castillo J, Serena J, Noya M: Duration of glutamate release after acute ischemic stroke. Stroke 1997;28:708-710.